Stay updated on CD40-L Blockade in GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40-L Blockade in GVHD Prevention Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The screen now shows an updated site revision/version indicator (“Revision: v3.5.3” instead of “Revision: v3.5.2”) for this record history page, reflecting a background release update rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T22:45:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision v3.5.2 is listed and the previous revision v3.5.0 is removed.
    Difference
    0.1%
    Check dated 2026-04-17T14:18:20.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new 'Study Status' entry was added to the record history on 2026-04-02 (version 31), with a preceding entry on 2026-03-31.
    Difference
    0.3%
    Check dated 2026-04-03T05:58:17.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:23.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-05T18:39:53.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A References section was added to the page to display cited sources for the study record.
    Difference
    0.1%
    Check dated 2026-02-26T13:53:14.000Z thumbnail image

Stay in the know with updates to CD40-L Blockade in GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.